Tuberculosis Epidemiology Studies Consortium

Award Date 9/29/2011
Last Date To Order 9/28/2020
Shared Ceiling $5.3M
Federal Agency
CDC Pittsburgh
Contract Type
Master IDIQ
Predecessor
Not listed
Successors

The Tuberculosis Epidemiology Studies Consortium (TBESC) is a Master Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the Centers for Disease Control and Prevention (CDC), specifically through the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention's Division of Tuberculosis Elimination. The contract's primary objective is to support research aimed at improving the diagnosis and treatment of Latent Tuberculosis Infection (LTBI). The research focuses on evaluating diagnostic methods, including Tuberculin Skin Test (TST) and Interferon Gamma Release Assays (IGRAs), and exploring strategies to enhance treatment adherence and completion.

The task orders under this IDIQ are consistently structured as cost-no-fee delivery orders, each valued between approximately $3.1 million and $5.1 million, with consistent performance periods through September 2021. Prime contractors include academic and healthcare institutions such as Duke University, University of Florida, University of North Texas Health Science Center, Denver Health and Hospital Authority, and state health departments like Maryland and Hawaii Department of Health. None of the task orders utilized set-aside designations, indicating open competition. The task orders uniformly focus on comparative studies of tuberculosis testing methodologies, specifically comparing TST and IGRA diagnostic approaches in latent tuberculosis infection patients, with an emphasis on understanding infection progression and developing more effective prevention and treatment protocols.

Generated 1/16/25, 12:05 AM